$2.04
00.00%
Pre-Market: 6:47 AM EDT
Comments
Loading...
Immuneering (IMRX) Forecast
NewsEarningsImmuneering (IMRX) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestImmuneering (NASDAQ:IMRX) Stock Quotes, Forecast and News Summary
Immuneering Stock (NASDAQ: IMRX) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Immuneering (IMRX) stock?
You can purchase shares of Immuneering (NASDAQ:IMRX) through any online brokerage.
Who are Immuneering (IMRX) competitors?
Other companies in Immuneering’s space includes: CytomX Therapeutics (NASDAQ:CTMX), bluebird bio (NASDAQ:BLUE), Cellectar Biosciences (NASDAQ:CLRB), Connect Biopharma Hldgs (NASDAQ:CNTB) and Aligos Therapeutics (NASDAQ:ALGS).
What is the forecast, or price target, for Immuneering (IMRX) stock?
Immuneering has a consensus price target of $17.60.
What is the current price for Immuneering (IMRX)?
The stock price for Immuneering (NASDAQ: IMRX) is $2.04 last updated November 21, 2024 at 6:47 AM EST.
Does Immuneering (IMRX) pay a dividend?
There are no upcoming dividends for Immuneering.
When is Immuneering (NASDAQ:IMRX) reporting earnings?
Immuneering’s Q3 earnings are confirmed for Wednesday, November 13, 2024.
Is Immuneering (IMRX) going to split?
There is no upcoming split for Immuneering.
What sector and industry does Immuneering (IMRX) operate in?
Immuneering is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.